Patient Ref. No.

121000001091702
DIAGNOSTIC REPORT
CLIENT CODE : C000037613
CLIENT'S NAME AND ADDRESS :
AARUSHI GUPTA SRL Ltd
SHOP-14, GOLF CITY, CIRCLE MART PLOT NO.8,
Sector 75, Noida, Uttar Pradesh 201301
UTTAR PRADESH, INDIA
Tel : 09111591115
CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : AARUSHI GUPTA PATIENT ID : AARUM041197121

ACCESSION NO : 0121VK001853 AGE : 25 Years SEX : Female

DRAWN : 06/04/2023 13:40 RECEIVED : 06/04/2023 13:42 REPORTED : 06/04/2023 16:35

REFERRING DOCTOR : SELF CLIENT PATIENT ID :

Test Report Status Final Results Biological Reference Interval Units

HAEMATOLOGY

CBC-5, EDTA WHOLE BLOOD

BLOOD COUNTS, EDTA WHOLE BLOOD

HEMOGLOBIN (HB) 15.2 13.0 - 17.0 g/dL
RED BLOOD CELL (RBC) COUNT 5.07 4.5 - 5.5 mil/µL
WHITE BLOOD CELL (WBC) COUNT 3.2 Low 4.0 - 10.0 thou/µL
PLATELET COUNT 151 150 - 410 thou/µL
RBC AND PLATELET INDICES
HEMATOCRIT (PCV) 44.5 40 - 50 %
MEAN CORPUSCULAR VOLUME (MCV) 88.0 83 - 101 fL
MEAN CORPUSCULAR HEMOGLOBIN (MCH) 29.9 27.0 - 32.0 pg
MEAN CORPUSCULAR HEMOGLOBIN 34.1 31.5 - 34.5 g/dL
CONCENTRATION(MCHC)
RED CELL DISTRIBUTION WIDTH (RDW) 13.0 11.6 - 14.0 %
MENTZER INDEX 17.4

MEAN PLATELET VOLUME (MPV) 11.4 High 6.8 - 10.9 fL

WBC DIFFERENTIAL COUNT
NEUTROPHILS 44 40 - 80 %
LYMPHOCYTES 45 High 20 - 40 %
MONOCYTES 10 2 - 10 %
EOSINOPHILS 1 1-6 %
BASOPHILS 0 0-2 %
ABSOLUTE NEUTROPHIL COUNT 1.41 Low 2.0 - 7.0 thou/µL
ABSOLUTE LYMPHOCYTE COUNT 1.44 1.0 - 3.0 thou/µL
ABSOLUTE MONOCYTE COUNT 0.32 0.2 - 1.0 thou/µL
ABSOLUTE EOSINOPHIL COUNT 0.03 0.02 - 0.50 thou/µL
ABSOLUTE BASOPHIL COUNT 0 Low 0.02 - 0.10 thou/µL
NEUTROPHIL LYMPHOCYTE RATIO (NLR) 1.0

Interpretation(s)
RBC AND PLATELET INDICES-
Mentzer index (MCV/RBC) is an automated cell-counter based calculated screen tool to differentiate cases of Iron deficiency
anaemia(>13) from Beta thalassaemia trait (<13) in patients with microcytic anaemia. This needs to be interpreted in line with
clinical correlation and suspicion. Estimation of HbA2 remains the gold standard for diagnosing a case of beta thalassaemia
trait.
WBC DIFFERENTIAL COUNT-The optimal threshold of 3.3 for NLR showed a prognostic possibility of clinical symptoms to change
from mild to severe in COVID positive patients. When age = 49.5 years old and NLR = 3.3, 46.1% COVID-19 patients with mild
disease might become severe. By contrast, when age < 49.5 years old and NLR < 3.3, COVID-19 patients tend to show mild

Scan to View Details Scan to View Report

 Patient Ref. No. 121000001091702
DIAGNOSTIC REPORT
CLIENT CODE : C000037613
CLIENT'S NAME AND ADDRESS :
AARUSHI GUPTA SRL Ltd
SHOP-14, GOLF CITY, CIRCLE MART PLOT NO.8,
Sector 75, Noida, Uttar Pradesh 201301
UTTAR PRADESH, INDIA
Tel : 09111591115
CIN - U74899PB1995PLC045956
Email : [email protected]

disease.

Page 1 Of 3

Scan to View Details Scan to View Report

 Patient Ref. No. 121000001091702
DIAGNOSTIC REPORT
CLIENT CODE : C000037613
CLIENT'S NAME AND ADDRESS :
AARUSHI GUPTA SRL Ltd
SHOP-14, GOLF CITY, CIRCLE MART PLOT NO.8,
Sector 75, Noida, Uttar Pradesh 201301
UTTAR PRADESH, INDIA
Tel : 09111591115
CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : AARUSHI GUPTA PATIENT ID : AARUM041197121

ACCESSION NO : 0121VK001853 AGE : 25 Years SEX : Female

DRAWN : 06/04/2023 13:40 RECEIVED : 06/04/2023 13:42 REPORTED : 06/04/2023 16:35

REFERRING DOCTOR : SELF CLIENT PATIENT ID :

Test Report Status Final Results Biological Reference Interval Units

(Reference to - The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients ; A.-P. Yang, et al.; International
Immunopharmacology 84 (2020) 106504 This ratio element is a calculated parameter and out of NABL scope.

EIA - INFECTIOUS SECTION

DENGUE NS1 ANTIGEN TEST, SERUM

DENGUE NS1 ANTIGEN 119.66 High < 9.0 NEGATIVE

9-11 EQUIVOCAL
>11 POSITIVE

Interpretation(s)
DENGUE NS1 ANTIGEN TEST, SERUM-Dengue virus is transmitted by Aedes mosquitoes. It belongs to the genus Flavivirus and
has four serotypes, DEN-1, DEN-2, DEN-3, and DEN-4. Infection with one dengue serotype provides lifelong immunity to that
virus, but no cross protective immunity to the other serotypes. Human dengue infection causes a spectrum of illnesses ranging
from inapparent or mild febrile illness to severe to fatal hemorrhagic disease. WHO classifies dengue infections as primary or
secondary. It is believed that patients experiencing a secondary infection with heterologous serotypes have hig her risk of
complications, including Dengue Haemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS).

Test Utility:
Dengue NS1 antigen can be detected in serum from day 1 after onset of clinical signs, up to day 9. Dengue specific IgM can be
detected as early as 5 days after the onset of fever and generally persists for 30-90 days, although detectable levels may be
present rarely upto 8 months post-infection. IgM antibody is also produced in secondary and tertiary dengue infections, although
the response in some secondary and probably most tertiary infections is low level and transient. Dengue IgG levels usually start
rising at the end of 1st week in primary infection and persists for months and sometimes for life.
Patients with primary dengue infections usually are IgM positive & IgG negative with higher IgM concentrations, whereas
patients with secondary infections are usually both IgG and IgM positive with higher IgG concentrations.

Confirmed diagnosis of Dengue fever can be established in a suspected case with atleast one of the following tests:
1) Demonstration of NS1 antigen by ELISA
2) Demonstration of IgM antibody titre by ELISA in single serum sample,
3) IgG seroconversion in paired sera after 2 weeks with 4 fold rise in titre 4) Demonstration of viral nucleic acid by PCR

Limitations:
• Cross reactivity due to other flaviviruses infections (Tick-borne encephalitis, Japanese encephalitis etc) can give false positive
dengue test.
• Differential diagnoses during the acute phase of illness should include measles, rubella, influenza, typhoid, leptospirosis,
malaria, other viral hemorrhagic fevers, and any other disease that may present as a nonspecific viral syndrome.
**End Of Report**
Please visit www.srlworld.com for related Test Information for this
accession

Scan to View Details Scan to View Report

 Patient Ref. No. 121000001091702
DIAGNOSTIC REPORT
CLIENT CODE : C000037613
CLIENT'S NAME AND ADDRESS :
AARUSHI GUPTA SRL Ltd
SHOP-14, GOLF CITY, CIRCLE MART PLOT NO.8,
Sector 75, Noida, Uttar Pradesh 201301
UTTAR PRADESH, INDIA
Tel : 09111591115
CIN - U74899PB1995PLC045956
Email : [email protected]

Dr. Ruchita Dr. Shavi

Mahajan Consultant Mahajan
Microbiologist Labhead-
Pathologist

Page 2 Of 3

Scan to View Details Scan to View Report

 Patient Ref. No. 121000001091702
DIAGNOSTIC REPORT
CLIENT CODE : C000037613
CLIENT'S NAME AND ADDRESS :
AARUSHI GUPTA SRL Ltd
SHOP-14, GOLF CITY, CIRCLE MART PLOT NO.8,
Sector 75, Noida, Uttar Pradesh 201301
UTTAR PRADESH, INDIA
Tel : 09111591115
CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : AARUSHI GUPTA PATIENT ID : AARUM041197121

ACCESSION NO : 0121VK001853 AGE : 25 Years SEX : Female

DRAWN : 06/04/2023 13:40 RECEIVED : 06/04/2023 13:42 REPORTED : 06/04/2023 16:35

REFERRING DOCTOR : SELF CLIENT PATIENT ID :

Test Report Status Final Results Biological Reference Interval Units

CONDITIONS OF LABORATORY TESTING & REPORTING

1. It is presumed that the test sample belongs to the patient 5. The results of a laboratory test are dependent on the
named or identified in the test requisition form. quality of the sample as well as the assay technology. 2. All Tests are
performed and reported as per the 6. Result delays could be because of uncontrolled turnaround timestated in the
SRL Directory of services circumstances. e.g. assay run failure.
(DOS). 7. Tests parameters marked by asterisks are excluded from
3. SRL confirms that all tests have been performed or the “scope" of NABL accredited tests. (If laboratory isassayed
with highest quality standards, clinical safety & accredited).
technical integrity. 8. Laboratory results should be correlated with clinical
4. A requested test might not be performed if: information to determine Final diagnosis.
a. Specimen received is insufficient or inappropriate 9. Test results are not valid for Medico- legal purposes. specimen
quality is unsatisfactory 10. In case of queries or unexpected test results please call
b. Incorrect specimen type at SRL customer care (Toll free: 1800-222-000). Post proper
c. Request for testing is withdrawn by the ordering doctor investigation repeat analysis may be carried out. or
patient
d. There is a discrepancy between the label on thespecimen container and the name on the test requisition form
SRL Limited
Fortis Hospital, Sector 62, Phase
VIII, Mohali 160062

Page 3 Of 3

Scan to View Details Scan to View Report